The Five-Factor Model Approach to Hypertensive Patients: A Case Control Study-Reference-Cited by-同舟云学术

The Five-Factor Model Approach to Hypertensive Patients: A Case Control Study

Published:2021-12-01 Issue:4 Volume:26 Page:14-17
ISSN:2285-7079
Container-title:Acta Medica Transilvanica
language:en
Short-container-title:

Author:

Lakatos Eva-Katalin¹²,Nireștean Aurel¹³

Affiliation:

1. “George Emil Palade” University of Medicine, Pharmacy, Science and Technology of Târgu Mureș ,

2. Emergency County Hospital Satu-Mare ,

3. Clinic of Psychiatry II , Târgu Mureș

Abstract

Abstract Objectives: The aim of this case-control pilot study was to examine whether there are differences in personality characteristics between hypertensive and normotensive individuals in terms of the Five-Factor Model (FFM). Methods: 71 individuals with primary hypertension were compared with 84 normotensive individuals on the DECAS personality inventory, assessing the five basic dimensions of personality according to the FFM. Results: Agreeableness and emotional stability were associated with hypertension (p-0,0001 for both). Hypertensive individuals showed low and very low agreeableness and emotional stability whereas normotensives scored medium and high in these two dimensions. Lower emotional stability was a risk factor for hypertension (OR=4.51, CI 95%=2.18-9.35). There were no significant differences in openness, extraversion and consciousness between hypertensives and normotensives (p>0.05). Conclusion: Individuals with low emotional stability/high neuroticism have more than fourfold increased risk of developing hypertension.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.2478/amtsb-2021-0062

Reference25 articles.

1. 1. Kaplan NM. Systemic Hypertension: Mechanisms and Diagnosis. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Braunwald’s Heart Disease. A textbook of Cardiovascular Medicine. 9th ed. Philadelphia: Elsevier Saunders; 2012. p. 935-954.

2. 2. Dorobantu M, Tautu OF, Dimulescu D, Sinescu C, Tatomir GP, Georgescu AC, et al. Perspectives on hypertension’s prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey. Journal of Hypertension. 2018;36(3):690-700.10.1097/HJH.000000000000157229035940

3. 3. Cuffee Y, Ogedegbe C, Williams NJ, Ogedegbe G, Schoenthaler A. Psychosocial risk factors for hypertension: an update of the literature. Curr Hypertens Rep. 2014;16(10):483.10.1007/s11906-014-0483-3416392125139781

4. 4. Williams B, Mancia G, Spiering W, Rosei AE, Azizi M, Burnier M, et al. 2018 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal. 2018;39:3021–3104.10.1093/eurheartj/ehy33930165516

5. 5. Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas CK, Back M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). European Heart Journal. 2021;42(34):3227-3337.10.1093/eurheartj/ehab48434458905